Introduction {#sec1}
============

Mononuclear phagocytes (MP; monocytes and tissue macrophages) play a prominent role in human immunodeficiency virus (HIV) transmission, viral tissue dissemination, and disease pathogenesis.^[@ref1]−[@ref6]^ Although MP serve as long-lived viral reservoirs,([@ref2]) the biological outcomes of virus-cell interactions are multifaceted and can lead to symbiosis or cell death.([@ref1]) For the virus, latency, restriction, or progeny virion production are the final outcomes of cell infection and are closely aligned to cell differentiation and activation.([@ref3]) Without a doubt, HIV-1 serves as a conductor for its own regulation, utilizing cross interactions between its own constituents and MP factors.([@ref4]) Importantly, while viral infection is modulated through host cell factors, the virus, in turn, influences MP function. The inevitable outcome may change during the viral life cycle and as infection persists.([@ref7]) Even after a quarter century of study, how such events occur and what level of MP viral infection influences cytotoxicity remains unclear and poorly defined.

MP protein synthesis can change during differentiation and activation or be cued by the virus itself to either propel or restrict viral growth.^[@ref4]−[@ref6]^ As per the latter, cell responses to infection ultimately break down and sustain viral growth.([@ref8]) The mechanisms by which such activities occur can now be deciphered through the advent of new technologies developed for protein identification and quantification. Sampling and analysis may now be performed at specific times following viral exposure and, as such, could begin to elucidate the biochemical mechanisms operative during the interplay between the virus and its host cell. One means to achieve this goal is through stable isotope labeling of amino acids in cell culture (SILAC). The technique is used commonly to identify differential expression of proteins in studies utilizing cell lines.^[@ref9],[@ref10]^ More recently, pulsed SILAC (pSILAC) was developed for quantitation of *de novo* cellular protein synthesis, without the necessity for complete label incorporation.([@ref11]) Application of pSILAC is ideal for studying nondividing cells during defined time periods and for quantifying differential protein expression rates.([@ref12]) Use of SILAC to assess macrophage infection, activation, and function is new to cell biology since it was introduced only two years ago to study transformed cell lines.^[@ref13]−[@ref17]^ For the first time, we now report changes in *de novo* protein synthesis for HIV-1-infected primary human monocyte-derived macrophages (MDM) as determined by pSILAC. The identified MDM responses to HIV-1 infection included robust changes in synthesis rates of several protein classes, including those linked to interferon (IFN) signaling and antigen presentation. The most significant protein groupings were related to cell fusion events, including DNA packaging and chromatin remodeling. pSILAC offers a comprehensive evaluation of protein synthesis dynamics that are operative during HIV-1 infection. The data serves also to validate studies performed in past decades, while shedding light onto unexplored areas of cellular responses to progressive HIV-1 infection.

Experimental Procedures {#sec2}
=======================

Cell Culture and Viral Infection {#sec2.1}
--------------------------------

Primary human monocytes were obtained through leukophoresis of donors that were seronegative for HIV-1, HIV-2, and hepatitis and were purified by countercurrent centrifugal elutriation.([@ref18]) Cells were plated in Dulbecco's Modified Eagle's Media supplemented with 10% human serum, 2 mM [l]{.smallcaps}-glutamine, 2 μg/mL macrophage colony stimulating factor (MCSF, a generous gift from Pfizer Inc., Cambridge, MA), 10 μg/mL ciprofloxacin and 50 μg/mL gentamicin (complete media). Three million cells/well were plated in 6 well plates at a density of one million cells/mL. Half of the media was exchanged every other day. At day seven, media was removed and cells infected with the HIV-1~ADA~ strain at a multiplicity of infection (MOI) of 0.1 infectious viral particles per cell. Productive HIV-1 infection was monitored by reverse transcriptase (RT) activity in culture supernatant fluids collected on days 3, 5, and 7 following HIV-1 infection (data not shown).

Addition of SILAC Medium {#sec2.2}
------------------------

SILAC medium was prepared using two different combinations of isotopically labeled [l]{.smallcaps}-Arginine and [l]{.smallcaps}-Lysine: "Medium" complete macrophage media, where [l]{.smallcaps}-Arginine and [l]{.smallcaps}-Lysine were replaced with \[^13^C~6~\]-[l]{.smallcaps}-Arginine and \[D~4~\]-[l]{.smallcaps}-Lysine (SIGMA-Isotec, St Louis, MO), and "Heavy" complete macrophage media, where [l]{.smallcaps}-Arginine and [l]{.smallcaps}-Lysine were replaced with \[^13^C~6~, ^15^N~4~\]-[l]{.smallcaps}-Arginine and \[^13^C~6~, ^15^N~2~\]-[l]{.smallcaps}-Lysine (SIGMA-Isotec, St Louis, MO).([@ref12]) SILAC media without MCSF was added on days 1, 3, or 5 following HIV-1 infection and cells lysed 48 h following SILAC medium addition. "Medium" macrophage media was applied to uninfected control cells and "Heavy" was applied to infected cells (Figure [1](#fig1){ref-type="fig"}). This was repeated with three independent donors.

![pSILAC experimental design for HIV-1 infection of primary human macrophages. Control cells were treated for 48 h with \[^13^C~6~\]-[l]{.smallcaps}-Arginine and \[D~4~\]-[l]{.smallcaps}-Lysine, while at the same time, HIV-1-infected cells were treated with \[^13^C~6~, ^15^N~4~\]-[l]{.smallcaps}-Arginine and \[^13^C~6~, ^15^N~2~\]-[l]{.smallcaps}-Lysine. MDM were lysed and protein was quantified. Equal amounts of protein were combined, separated by OFFGEL electrophoresis, sequenced by LC--MS/MS and quantified using MaxQuant.](pr-2011-00124j_0001){#fig1}

Cell Lysis and Sample Preparation {#sec2.3}
---------------------------------

After 48 h incubation in SILAC media, all media was removed, cells were washed with PBS and lysed in lysis buffer (4% sodium dodecyl sulfate, 0.1 M dithiothreitol, 0.1 M Tris-HCl, pH 7.6); cells scraped and collected; and lysates boiled. Protein concentrations of the lysates were determined by Pierce 660 Assay (Thermo Fisher Scientific, Rockford, IL) At each sample day, 50 μg of protein from infected cells were combined with 50 μg of protein from uninfected control cells. Combined lysates were diluted in UA (8 M Urea, 0.1 M Tris-Hcl, pH 8.5), applied to a 30 kDa molecular weight cutoff centrifugal filter (Millipore, Bellerica, MA), and centrifuged at 14 000× *g* for 15 min. Lysates were washed with UA and centrifugation was repeated. IAA (0.5 M iodoacetamide) was added to the filter, incubated at room temperature, and the filter centrifuged at 14 000× *g* for 10 min. The filter unit was washed with UA, and centrifugation was repeated. ABC (0.05 M NH~4~HCO~3~) was added to the filter, centrifuged, and repeated once. Two micrograms of trypsin (Promega, Madison, WI) in ABC was applied to the filter, mixed for 1 min, and incubated for 18 h at 37 °C in a humidified chamber. The filter-containing digested peptides was transferred to a new collection tube and centrifuged at 14 000× *g* for 10 min. The filter was washed with 0.5 M NaCl and centrifuged at 14 000× *g* for 10 min \[adapted from ref ([@ref19])\]. The digested sample was brought to 1 mL total volume with 0.2% formic acid. The acidified protein was added to a wet MXC 30 mg extraction cartridge (Waters-Oasis, Milford, MA) in 1 mL 50% methanol, and the cartridge was washed with 1 mL of 5% methanol/0.1% formic acid, then 100% methanol. The proteins were eluted with 1 mL elution buffer (1.4% NH~3~OH in methanol) and dried using a SpeedVac.

Isoelectric Focusing/Fractionation and Mass Spectrometry Sample Preparations {#sec2.4}
----------------------------------------------------------------------------

Dried samples were resuspended and separated by isoelectric focusing through OFFGEL electrophoresis (Agilent, Santa Clara, CA) following the manufacturer's suggested protocol for separating peptides.([@ref20]) Samples were separated on a pH 3--10 strip and collected into 12 wells. Wells were washed with 200 μL 50% methanol/1% formic acid. Wash was collected, dried in a SpeedVac, and previously collected samples from the corresponding wells were combined with the dried wash.([@ref21]) Fractions collected from OFFGEL electrophoresis were mixed 3 parts sample to 1 part 2% trifluoroacetic acid (TFA) and 20% acetonitrile (ACN). C18 spin columns (Thermo Fisher, Rockford, IL) were placed in collection tubes and activated by the addition 100% ACN, followed by being washed with 0.5% TFA and 5% ACN. Diluted samples were applied to the prewet column twice and washed with 0.5% TFA and 5% ACN. The column was placed in a new receiver tube, and peptides were eluted with the addition of 70% ACN. Samples were dried using a SpeedVac and resuspended in 6 μL 0.1% formic acid for LC--MS/MS analysis.

Mass Spectrometry {#sec2.5}
-----------------

An LTQ Orbitrap XL with Eksigent nano-LC system was used, equipped with two alternating peptide traps and a PicoFrit C18 column-emitter (New Objective, Woburn, MA). Samples were loaded onto the peptide trap with 98:2 HPLC water with 1% formic acid: ACN with 1% formic acid and eluted using a 60 min linear gradient of 0--60% ACN with 1% formic acid. The instrument was tuned using direct infusion of angiotension and calibrated every 2--3 days using standards provided by the manufacturer with Lock Mass. The acquisition method was created in data-dependent mode with one precursor scan in the Orbitrap, followed by fragmentation of the 5 most abundant peaks in the CID, detected in the LTQ. Resolution of the precursor scan was set to 60 000, scanning from 300 to 2000 *m*/*z*. Precursor peaks were dynamically excluded after two selections for 60 s. No charge state rejection was used, but previously detected background peaks were included in a mass rejection list. Collision energy was set to 35 using an isolation width of 2 and an activation *Q* of 0.250.

Quantification and Identification {#sec2.6}
---------------------------------

Files obtained from LTQ-Orbitrap were submitted to MaxQuant (version 1.0.13.8) for peak list generation. The peak list files were searched using Mascot (Matrix Science, Boston, MA) against the International Protein Index (IPI) human database for protein identifications. The search parameters were set as 2 maximum missed cleavages; Carbamidomethyl (C) as fixed modification; *N*-acetyl (Protein) and Oxidation (M) as variable modifications; top 6 MS/MS peaks per 100 Da; and MS/MS mass tolerance of 0.5 Da. Output files from Mascot were submitted back to MaxQuant for final identifications and validation. MaxQuant was used because of its abilities to provide quantitative analysis of large mass spectrometric data sets acquired when performing pSILAC for high-resolution peptide pair detection. Different mass measurements were corrected for achieving mass accuracy. One unique peptide with a minimum length of 6 amino acids was required. A false discovery rate of 0.01 was applied for both protein and peptide identification, ensuring that at most only 1% of proteins would be falsely identified. Ratios were obtained for HIV-1-infected ("Heavy") MDM to Uninfected ("Medium") MDM comparisons for days 3, 5, and 7 following infection. Significant protein ratio cutoff was set at a Significance B value ≤0.05 as calculated by MaxQuant.^[@ref22],[@ref23]^ Since proteins of high abundance have high-intense signals and can be measured more accurately than ones with low abundance, we used the B-value because it groups the proteins of similar intensities into bins of equal occupancy and estimates the standard deviation of the protein ratios using the protein subset grouped into the same intensity bin. Contaminants and reverse hits identified by MaxQuant were excluded from further analysis. Heatmap was generated using pretty heatmap package in R.([@ref24]) Expression pathways were created using Ingenuity Pathway Analysis (IPA, Ingenuity Systems, Inc., Redwood City, CA) version 8.8.

Bioinformatic Analyses {#sec2.7}
----------------------

The proteins that were determined significant by MaxQuant analyses were analyzed with functional profiling tools. A two-step approach was used where significantly differentially expressed proteins were first selected. For bioinformatic analyses, official gene names corresponding to the proteins identified were determined using an internal computational tool. This tool cross-references databases from ENSEMBL and NCBI (our unpublished work). To obtain gene lists for proteins present uniquely or commonly among the three time points, the intersection of genes was determined computationally. Insights into biological processes were investigated by FatiGO,([@ref25]) which uses Gene Ontology (GO)([@ref26]) and Kyoto Encyclopedia of Genes and Genomes (KEGG)([@ref27]) for functional annotations. This extended the search for biological interpretations of the data set to other databases such as the Reactome and Interpro. Functional significance of data collected was measured by Fisher's exact test using 2 × 2 contingency tables. A low *p*-value of 0.05 indicated a significant association, and the adjusted *p*-values were calculated using the false discovery rate (FDR) method.([@ref28])

In creating gene lists, an imposition of threshold was performed. The data was analyzed as described, or correlation analyses were used. The threshold-based method ignores the cooperative behavior among genes, while the correlation analysis incorporates this property. Using the threshold-based method, we obtained a total of 297 unique and 57 common genes that were included in the functional enrichment study. Using the MaxQuant generated log~2~(H/M) values from the three experimental time points, gene-to-gene Pearson's correlation coefficients were calculated. A network of highly correlated genes (\>95%) was used in the construction of a graph network. The gene network topology was analyzed using Cytoscape 2.6.3,([@ref29]) and the densely correlated gene clusters were identified using MCODE V1.2([@ref30]) available as a plug-in for Cytoscape.

HIV-1p24 Immunohistochemistry {#sec2.8}
-----------------------------

Monocytes were plated at a density of 10^6^ cells/mL, propagated in complete media, infected with virus (MOI of 0.1), and then stained for HIV-1p24 proteins. Briefly, cells were fixed in 4% paraformaldehyde, permeabilized with 1% Triton X-100, washed in PBS, and blocked with 10% bovine serum albumin. HIV-1p24 Ab (Santa Cruz Biotechnology, Santa Cruz, CA) was used at a 1:100 dilution in 10% BSA according to established protocols.([@ref31])

Results and Discussion {#sec3}
======================

MP display a range of functional innate immune activities for host survival and homeostasis, including: clearance of debris, intracellular destruction of pathogens, and secretion and presentation of bioactive chemicals and peptides that help orchestrate an immune response. In addition, the same cells serve as primary targets for a variety of microbial pathogens, including HIV-1. Indeed, MP support productive HIV-1 infection and are impacted, in structure and function, by both viral and cellular products serving to sustain or restrict the viral life cycle.([@ref32]) Virus infection of MP induces a plethora of intracellular activities that affect antiretroviral immunity but fail, collectively, to eliminate the viral pathogen. The mechanism(s) by which this occurs remains incompletely understood. While studies have been performed to elucidate the host proteins required for HIV-1 infection,([@ref33]) little was done to elucidate dynamic host protein expression during the course of infection in primary macrophages. Thus, to better determine the consequences of virus-macrophage interactions, we employed pSILAC to examine differential protein expression during the course of infection. This approach is novel, as it allows examination of *de novo* protein synthesis, and as such, is reflective of viral--host cell dynamics.

To link viral replication to protein identifications, we stained infected cells for HIV-1p24 to document the course of HIV-1~ADA~ infection at the time points examined by proteomics. The percentages of infected cells increased over time and are illustrated in Figure [2](#fig2){ref-type="fig"}. On days 3, 5 and 7, 17.6 ± 3.7, 44.0 ± 9.1 and 70.7 ± 4.4% of the MDM were HIV-1p24 positive, respectively. HIV-1~ADA~ MDM infection levels correlated with the formation of multinucleated giant cells (Figure [2](#fig2){ref-type="fig"}); a stage of infection when cell death is not prominent.([@ref18]) It is understood that cell death can result after long-standing infection (2 weeks or longer). This occurs, in part, due to laboratory adaptation of the HIV-1~ADA~ strain used in study. Virus-induced macrophage death is not typical of either primary HIV-1 isolates or with the this current strain when MDM are infected for one week at an MOI of 0.1.

![MDM immunostained for HIV-1p24 protein expression calculated as percent of HIV-1p24 positive cells, expressed as ±1 standard deviation of the mean. Illustrated are (A) control, uninfected MDM and HIV-1-infected MDM on (B) day 3, (C) day 5, and (D) day 7 after viral infection.](pr-2011-00124j_0002){#fig2}

A total of 393 proteins were identified as differentially expressed, with significance values of ≤0.05 for at least one of the 3 time points examined after HIV-1 infection (Figure [3](#fig3){ref-type="fig"}a). At all time points, 28 proteins were identified as differentially expressed. The number of proteins that were identified between only two of the time points were similar in quantity, no matter which overlapping days were examined. Thirty-two, 28, and 24 common proteins with significant ratios between infected and uninfected MDM were observed on days 3 and 5, 5 and 7, or 3 and 7 after infection, respectively. The numbers of unique proteins with differentially expressed synthesis rates at single time points were 99, 77, and 105 on days 3, 5, and 7 after infection, respectively. These differences demonstrate that the cellular response to HIV-1 infection change during the course of viral infection.

![(A) Venn diagram of the overlap in protein identification with significant ratios (Significance B ≤ 0.05) between days 3, 5, and 7. Distribution of log~2~ transformed protein expression ratios of HIV-1 to control on (B) day 3, (C) day 5, and (D) day 7 post HIV-1 infection. Ratios are graphed versus intensity.](pr-2011-00124j_0003){#fig3}

pSILAC ratios were obtained comparing the levels of newly synthesized proteins in HIV-1-infected MDM to their time-matched uninfected controls. On each day, there were proteins with significantly different ratios, as indicated by B values ≤0.05, and with changes (up or down regulation) in rates of new protein synthesis between HIV-1 infected cells and replicate uninfected controls (Figure [3](#fig3){ref-type="fig"}b--d). While differentially expressed proteins showed similar findings, their distribution was not constant during the course of viral infection (Figure [3](#fig3){ref-type="fig"}a). Indeed, MDM protein levels in response to HIV-1 infection was altered as viral infection progressed, reflecting time-dependent variances in protein expression rates.

A complete list of all significant proteins and their corresponding fold change are included in Supplemental Table 1 ([Supporting Information](#notes-1)). The highest scoring interaction network identified by IPA for day 7 of infection identified significant upregulation in *de novo* synthesis of IFN-induced proteins (Figure [4](#fig4){ref-type="fig"}), therefore, indicating that the rate of antiviral response by the macrophage increased as HIV-1 infection progressed. These antiviral proteins affect different points during the viral life cycle (Supplemental Figure 1, [Supporting Information](#notes-1)). Although numerous antiviral proteins were up-regulated \[including: 2′-5′-oligadenylate sythetase 2 (2--5 OAS2), signal transducers and activators of transcription 1 (STAT1), IFN-induced guanylate-binding protein 1 and 2 (GBP1, GBP2), IFN-induced GTP-binding protein Mx1 (Mx1), and bone marrow stromal antigen 2 (BST2 or tetherin)\], virus production increased over time, therefore allowing cells to secrete progeny virus or to spread infection to nearby cells ([Supplemental Figure 1](#notes-1)). While it is known that MCSF-differentiated macrophages display an M2 anti-inflammatory phenotype,([@ref34]) it is known that HIV-1 induces an M1 inflammatory phenotype at early stages of infection.([@ref6]) This commonly results in IFN production and secretion of pro-inflammatory factors^[@ref5],[@ref35]^ demonstrating innate antiretroviral responses of MDM.

![(A) IFN signaling pathway coded with identified proteins on day 7 postinfection. Gray proteins were identified but did not reach statistical significance. (B) Ingenuity Pathway Analysis highest scoring interaction network. Increased synthesis rates are indicated by increasing intensity of red; decreased synthesis rates are denoted in green.](pr-2011-00124j_0004){#fig4}

STAT1 was upregulated at all 3 time points that were examined at 2-day intervals after infection. STAT1 is known to be an IFN-induced transcription factor (Supplemental Figure 1, [Supporting Information](#notes-1)). Its expression leads to the induction of downstream antiviral genes, such as 2--5 OAS and tetherin,([@ref36]) both of which had increased rates of synthesis. Interestingly, others found that IFN-induction of STAT1 can lead to an initial phosphorylation of STAT1, but a prolonged upregulation of unphosphorylated STAT1 can induce antiviral gene expression independent of STAT1 phosphorylation.([@ref36]) This could explain the increased and prolonged rates of synthesis of new STAT1 identified in our study, which translates to upregulation of antiviral genes and further substantiating that MDM employ multiple mechanisms to clear virus and permit host cell survival.

Tetherin binds budding HIV-1 virions to the cell membrane, and thus inhibits their release. Viral protein U (Vpu) can inhibit tetherin expression by binding tetherin at the membrane leading to down-regulation of tetherin at the cell surface([@ref37]) (Supplemental Figure 1, [Supporting Information](#notes-1)). Tetherin not only inhibits virion release, but also cell-to-cell viral transfer.([@ref38]) We saw an initial down-regulation of tetherin synthesis on D3 that transitions to up-regulation on D5 and progressing even further by D7. This increase in the synthesis rate may be an effort to bypass Vpu inhibition in a futile attempt to control viral propagation. Another IFN-induced antiviral protein, 2--5 OAS2, exhibited an increased rate of synthesis in our study was shown to be elevated in individuals afflicted with acquired immune deficiency syndrome (AIDS) compared with uninfected controls.([@ref39]) In simian immunodeficiency virus models, 2--5 OAS2 expression is elevated in those subjects with a more rapid progression toward AIDS.([@ref40]) HIV-1 is known to have mechanisms to evade the interferon-induced effects of 2--5 OAS2.([@ref41]) Tat binding to the transactivation responsive region of HIV-1 mRNA blocks 2--5 OAS2 binding, therefore preventing 2--5 OAS2 activation.([@ref42]) While we have identified an increasing rate of 2--5 OAS2 synthesis as HIV-1 infection progresses, viral infection is not diminished as demonstrated by both HIV-1p24 staining and RT activity. Mx1 and GBP ([Supplemental Figure 1](#notes-1)) both have roles in the inhibition of hepatitis C.^[@ref43],[@ref44]^ Mx1 also has been implicated in inhibiting influenza viral growth,([@ref45]) and GBP is known to inhibit both vesicular stomatitis and encephalomyocarditis viruses.([@ref46]) MX1 induction during HIV-1 infection has been identified by multiple groups.([@ref47]) Thus, extensive identification of IFN-induced antiviral proteins that have increased synthesis during HIV-1 infection confirms pSILAC as a suitable technology for detecting protein synthesis changes in nondividing MDM.

ENSEMBL Gene Identifiers for corresponding proteins within a group were obtained for functional classification of identified proteins. The number of unique genes identified for the three days are listed in Table [1](#tbl1){ref-type="table"} and were further analyzed for functional classification. To begin looking for novel protein synthesis changes that occurred during HIV-1 infection of MDM and were identified by pSILAC, corresponding genes were grouped by their functional classification using FatiGO, a functional enrichment tool available in the Babelomics software. Only groupings of genes scoring a p-value ≤0.01 were considered significant and used for further analyses. We examined GO terms that contained significant groupings of unique proteins identified in a minimum of two time points. To this end, a significant number of protein groups on each of the days corresponded to one GO term, but the individual proteins identified between days were unique. Such analyses bridged the data set to functional biology of the macrophage. In this way, the impact of protein groups with specific functions was realized as significant for virus-infected cells.

###### Number of Unique Genes Used for Babelomics Functional Annotation Following Parsing of Original Significant MaxQuant Protein Groupings

  treatment   significant MaxQuant proteins   ENSEMBLE gene identifiers   unique genes
  ----------- ------------------------------- --------------------------- --------------
  Day 3       184                             221                         98
  Day 5       165                             201                         76
  Day 7       186                             248                         123

Through investigations of new protein synthesis observed during short time periods, we can elucidate an evolving MDM response to HIV-1 infection. Understanding the compensatory changes in MP biology after viral infection is key to identifying both how the cell responds to progressive HIV-1 infection and the mechanisms by which HIV-1 modulates the cellular response to its benefit. In this regard, a number of cellular protein classes changed their rate of synthesis as a consequence of infection. While many groups of proteins were determined to be significantly altered, we chose to focus our attention on the most enriched functional groupings; those grouped under the GO terms: telomere maintenance, chromatin assembly or disassembly, DNA packaging, and nucleosome assembly. Each of these groups is marked with an asterisk in Table [2](#tbl2){ref-type="table"} and had a minimum of 15 unique genes associated with D7 or D3 along with separate unique genes associated with all three days of infection. While telomere maintenance was identified as an enriched grouping, these proteins were all histones, known to be involved in cellular regulatory processes. Proteins linked only to the maintenance of telomeres were not identified and would be expected since human MDM are nondividing cells. The groupings related to the control of DNA packaging and chromatin assembly are likely linked to virus-induced cytopathology, which is highly significant for the HIV-1~ADA~ strain.

###### Functional Annotation of Genes Using Babelomics[a](#tbl2-fn1){ref-type="table-fn"}

                                                                                             number of unique genes            
  --------------------------------------------------------------------- -------------------- ------------------------ --- ---- ----
  3′ -UTR-mediated translational regulation                             Reactome                                      4   4     
  APC/C:Cdh1-mediated degradation of Skp2                               Reactome             3                            5     
  Cdc20:Phospho-APC/C mediated degradation of Cyclin A                  Reactome             3                            5     
  Cell cycle, Mitotic                                                   Reactome             7                            7     
  Diabetes pathways                                                     Reactome             7                            7     
  DNA replication                                                       Reactome             4                            5     
  Gene expression                                                       Reactome             7                            8     
  HIV infection                                                         Reactome             4                            7     
  Metabolism of amino acids                                             Reactome             5                            7     
  Regulation of activated PAK-2p34 by proteasome mediated degradation   Reactome             3                            5     
  Signaling by Wnt                                                      Reactome             3                            5     
  Telomere Maintenance\*                                                Reactome                                          15   8
  Fatty acid metabolism                                                 Kegg Pathway         4                            4     
  Proteasome                                                            Kegg Pathway         3                            5     
  Chromatin assembly or disassembly\*                                   Biological Process                                20   27
  DNA packaging\*                                                       Biological Process                                21   27
  Nucleosome assembly\*                                                 Biological Process                                18   27

Numbers in each column correspond to the number of unique genes expressed only at that day.

MaxQuant protein groups were also examined in parallel for interactions between one another and to provide confirmation and extensions of the protein maps. Indeed, by performing cluster analysis, we selected two clusters that included interactions from highly significant groupings that are linked to macrophage functions. The first cluster demonstrates specific interactions between DNA packaging, chromatin assembly/disassembly, and nucleosome assembly, along with fatty acid oxidation and antigen processing and presentation (Figure [5](#fig5){ref-type="fig"}, Supplemental Figure 2, [Supporting Information](#notes-1)). In the second cluster, we identified interactions that appeared to split between two distinct groups (Supplemental Figures 3 and 4, [Supporting Information](#notes-1)). The first was between transcription initiation, nucleosome assembly, chromatin assembly/disassembly, DNA packaging, second messenger signaling and phosphoinositide-mediated signaling. The second was involved in the immune system and developmental regulation, including negative regulation of cellular differentiation, regulation of immune system processes, myeloid cell differentiation, megakaryocyte differentiation, hemopoiesis, and immune system development. A third, but less significant, contributor was the regulation of ubiquitin-protein ligase activity (both positive and negative).

![Enriched protein classifications for the correlation network in Supplemental Figure 2 ([Supporting Information](#notes-1)).](pr-2011-00124j_0005){#fig5}

The cytopathology of HIV-1 infected MDM has been the topic of previous studies investigating cytoskeletal transformation, multinucleated giant cell formation, and HIV-1-associated neurodegeneration.^[@ref8],[@ref35]^ Less studied are the protein changes resulting in these cytopathological findings. The epigenetic control of HIV-1 viral latency has been the subject of many recent studies and helps to explain the cytopathicity of HIV-1 infection. While histone methylation, acetylation and deacetylation are utilized to control viral integration and expression,([@ref48]) histone synthesis and turnover is an area that has not been heavily investigated in relation to HIV-1 infection. We identified differential regulation in the synthesis rates of histone proteins, which are seen in our significant GO groupings (Figure [6](#fig6){ref-type="fig"}). Significant down-regulation in synthesis rates were identified in some histones by D3 post infection, and further down-regulation in the rates of protein synthesis were identified by days 5 and 7 following infection. Such a response is made when the host cell works to restrict viral dissemination in MDM. Indeed, histone recycling during transcription is thought to occur when it is necessary to replace modified histones, such as those that are methylated.([@ref49])

![Heatmap of log~2~ (H/M ratio) labeled by their gene name. Expression between days 3, 5, and 7 is colored with varying intensities ranging from blue to red; blue being the lowest ratio, red being the highest ratio, and yellow representing those ratios that equal one.](pr-2011-00124j_0006){#fig6}

In recent years, it has been determined that modified histones are often controlled by such molecules as histone methyltransferases, acetyltransferases, and deacetylases, without the need for histone recycling. In contrast, histone replacement from cellular pools is necessary following unwinding during transcription, substantiating the need for histone turnover for active transcription.([@ref50]) HIV-1 infection results in chromatin disruption, which likely contributes to the accessibility of transcription initiation sites to polymerases in productively infected cells.([@ref51]) Therefore, it is required to rearrange DNA packaging for successful proviral DNA insertion and subsequent transcription. While the location and modification status of histones commonly have been examined,([@ref52]) along with other mechanisms of epigenetic control of viral replication,([@ref53]) the rate of new histone synthesis has not been evaluated as a consequence of HIV-1 infection. Indeed, decreasing synthesis rates of macrophage histone proteins may therefore serve a dual function in altering cellular structure and metabolism. First, it may permit improved engagement of the HIV-1 promoter to facilitate active viral replication, and second, an overall decrease in transcription, or rearrangement of chromatin, can effect more globally altered gene expression as the host works to protect the cell from ongoing virus-induced damage.

The findings also support the idea that the macrophage has an initial burst in protein synthesis rates required for antigen (AG) presentation to both CD4+ and CD8+ T cells as an attempt to control viral infection. This response is likely attenuated over time as the mechanism by which macrophages work to clear virus and protect the host, shifts and begins to break down. Interestingly, the AG presentation protein group includes a variety of major histocompatibility complex (MHC) class I and MHC class II proteins. Its synthesis was most heavily upregulated at day 3 compared with the later days, 5 and 7, of infection (Figure [6](#fig6){ref-type="fig"}). As virus replication progressed, AG presentation-related protein synthesis rates consistently increased compared to controls; but the level of upregulation was decreased over time. It is noteworthy that AG presentation to T cells is a major function of macrophages and represents, along with phagocytosis, intracellular killing, mobility, and secretion of bioactive substances, the host's primary defense in engaging an immune response to contain microbial infection. Thus, up-regulation in both, MCH Class I and II AG presenting proteins that are reduced as HIV-1 infection ensues, likely follows a cellular response to control this ongoing microbial infection. During early infection, before large increases in viral replication overwhelms cellular control capacities, the macrophage attempts to control virus through its AG presentation capabilities. In support of this notion, and recently seen by others, Nef was implicated in both MHC I([@ref54]) and MHC II([@ref55]) down-regulation, further substantiating that HIV-1 modulates the macrophage to its benefit. Indeed, we found that as HIV-1 infection progresses, AG presentation activities are diminished. This can be due to a combination of cellular responses including Nef inhibition and modulation of macrophage protein expression leading to enhanced cell survival.

Conclusion {#sec4}
==========

Taken together our data support the idea that a delicate interplay exists between host survival and macrophage viral propagation. While ultimately HIV-1 persistence prevails, intricate cellular and viral regulatory events occur as the macrophage works to contain HIV-1 infection, despite the inevitable outcome to the cell. HIV-1 in turn acquires unique protective mechanisms to support its own survival, while altering the MDM to its benefit. Indeed, our study highlights a range of antiretroviral mechanisms that develop in the macrophage for its benefit. Down-regulation of histone synthesis rates is one that portends more global outcomes for the cell. Altering DNA packaging ultimately alters transcription rates and cell process regulation. Ultimately, HIV-1 overcomes the antiretroviral macrophage protein armada. While working to contain viral growth, the macrophage fails, inevitably giving the virus and its dissemination the overriding edge. The future rests in finding the means to boost macrophage antiretroviral activities with the goal to both contain, then eliminate viral infection.
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